<DOC>
	<DOCNO>NCT02675855</DOCNO>
	<brief_summary>The objective study compare efficacy weekly GrafixPRIME® administration Active Comparator patient chronic DFUs randomize , single-blind study .</brief_summary>
	<brief_title>GrafixPRIME® Treatment Chronic Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Type 1 Type 2 Diabetes Chronic ulcer ( present ≥4 week , 52 week ) Index ulcer locate malleoli plantar dorsal surface foot Index ulcer extend dermis subcutaneous tissue without evidence expose muscle , tendon , bone joint capsule Adequate circulation foot ( document ABI TBI ) Gangrene present affect foot Index ulcer Charcot deformity Patient receive dialysis Patient 2 previous amputation Patient HbA1c &gt; 12 % random blood sugar &gt; 450 mg/dl Chronic oral steroid use Use IV corticosteroid , immunosuppressive , cytotoxic agent IV antibiotic Another ulcer within 5cm Index ulcer Cellulitis , evidence infection , osteomyelitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Grafix</keyword>
</DOC>